INmune Bio establishes global commercialization framework for Ebstrocel™ through strategic agreement with Uniphar
INmune Bio Inc. (the “Company”), a late-stage biotechnology company focused on inflammation and immunology, today announced that it has entered into a Master Services Agreement with Uniphar Durbin Ireland Limited…